Description

Thinking about starting peptide therapy? Establishing baseline biomarkers before treatment can help assess your current health status and provide objective measurements to monitor your progress over time.

Our Baseline Peptide Biomarker Panel is designed to evaluate key areas commonly affected by peptide therapy, including metabolic health, thyroid function, inflammation, and growth hormone activity.

Panel Includes:

  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel (CMP)
  • Lipid Panel
  • Hemoglobin A1c
  • Fasting Glucose
  • Fasting Insulin
  • IGF-1 (Insulin-Like Growth Factor-1)
  • hs-CRP (High-Sensitivity C-Reactive Protein)
  • TSH (Thyroid Stimulating Hormone)
  • Free T4
  • Free T3
  • Vitamin D (25-OH)

This panel is appropriate for individuals considering peptides such as BPC-157, TB-500, CJC-1295, Ipamorelin, MOTS-C, NAD+, and Retatrutide.

Already have recent lab work? Send us a copy of your results. We can customize your panel by removing biomarkers that have already been completed and adding tests specific to your health goals and planned peptide regimen.

Fasting recommended.